Mark E Nance Insider Trading $INSY Insys Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark E Nance.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark E Nance. Mark E Nance is Chief Legal Officer & Gen Cnsl in Insys Therapeutics, Inc. ($INSY) and General Counsel in Envista Holdings Corp ($NVST) and Senior Vice President, GC, Sec in Envista Holdings Corp ($NVST).
Mark E Nance in Insys Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark E Nance: Chief Legal Officer & Gen Cnsl
Holdings: 25,000 shares
Current Value: $249,000
Latest Transaction: Apr 23 2019
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark E Nance in Insys Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Oct 12 2018 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 8.61 | 100,000 | 861,000 | 100,000 | |
| Oct 12 2018 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1